Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways
Clinical and Molecular Hepatology. 2022;28(4):827-840 
TMAO Stimulate Inflammation and Lipid Accumulation via NF-κB Signaling Pathway in Nonalcoholic Fatty Liver Disease
. 2021;
Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway
Frontiers in Pharmacology. 2021;11:
Noninvasive Evaluation of Fibrosis and Steatosis in Nonalcoholic Fatty Liver Disease by Elastographic Methods
Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018;
Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
Nutrients. 2021;14(1):76
Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways
Biomedicine & Pharmacotherapy. 2021;141:111874
Protective Effect of Oligonol on Dimethylnitrosamine-Induced Liver Fibrosis in Rats via the JNK/NF-κB and PI3K/Akt/Nrf2 Signaling Pathways
Antioxidants. 2021;10(3):366
A polysaccharide of PFP-1 from Pleurotus geesteranus attenuates alcoholic liver diseases via Nrf2 and NF-κB signaling pathways
Food & Function. 2021;12(10):4591-4605
NS3TP1 promotes liver fibrosis by activating HSCs through TGFβ1/Smad3 and NF-κB/NLRP3 inflammasome signaling pathways
. 2022;
CXCL16 promotes hepatocyte steatosis and fibrosis in nonalcoholic fatty liver disease via hepatocyte-stellate cell crosstalk
Journal of Hepatology. 2018;68:S342